Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr Robert Stein Named CEO of KineMed

This article was originally published in Scrip

Executive Summary

KineMed (US) has named Dr Robert Stein chief executive officer and member of its board of directors. Dr Stein currently serves on the president's board of advisors for science and innovation for the University of California and is scientific advisor to Takeda San Diego. From 2003-06, he served as the site president at Roche's Palo Alto facility.

You may also be interested in...



Sanofi Has EU Insulin Aspart Biosimilar Approval

Sanofi has received formal approval from the European Commission for its insulin aspart biosimilar.

Rx-To-OTC Switch And RWE Key To Creating ‘Crisis Proof’ European Medicines System

Europe's self-care industry urges the European Commission to use Rx-to-OTC switch and real world evidence to widen access to OTC medicines in the region as part of its new pharmaceutical strategy. 

P&G Lacks Evidence To Support Vicks Efficacy Claims In UK Ad

Procter & Gamble failed to substantiate claims that Vicks First Defence can eliminate cold symptoms completely, says UK ad regulator ASA.

Topics

Related Companies

UsernamePublicRestriction

Register

PS140995

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel